conjugate

Through the acquisition, Novartis is also gaining access to a new class of RNA therapeutics, called antibody oligonucleotide conjugate, with a platform that enables delivering RNA therapy to muscle, UBS says.

Avidity is developing gene-based drugs that use an emerging technology known as antibody oligonucleotide conjugates to deliver RNA treatment to muscles.

They found elevated levels of conjugated bile acids and tested whether these compounds contributed to tumor growth.

Antibody drug conjugates are being developed for a range of cancers.

These include organic semiconductors of various kinds, as well as conjugated polymers for sensing and biomedical applications.